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Objectives: Health economic models typically follow a Markovian framework with 
discrete health states. The transition probability matrix (TPM), which characterizes 
the health state transitions, is the key driver of such a model. Estimation of TPM 
depends upon the observation intervals of clinical studies and the model cycle 
length. Generally Maximum-Likelihood (ML) or eigen-decomposition method can 
be used to estimate the TPM. However, these methods are not feasible for stud-
ies with non-uniform observation intervals (e.g., observations taken at 1, 3 & 6 
months), or when eigenvalues are negative or complex. The current objective is to 
provide a generalized algorithm to estimate TPM in all possible situations using 
all the available data. MethOds: Craig & Sendi (2002) illustrated an EM algorithm 
approach to estimate 1 month TPM for a 3-state model, where 1 and 2 month obser-
vations were available. We generalized this procedure and created an algorithm 
for any observation intervals and any number of states. We evaluated this algo-
rithm in the following situations: i) Observations at multiple intervals to estimate 
a single cycle TPM, ii) Seventh month observed transitions to estimate a 2-month 
TPM when the eigenvalues are complex, iii) Sixth month observed transitions to 
estimate a 2-month TPM when the eigenvalues are negative. Results: The gen-
eralized EM algorithm approach replicated results obtained from ML and eigen-
decomposition method. In cases where eigenvalues were negative and complex, 
this method provided solutions which were valid and interpretable. In all three 
situations mentioned above, the generalized EM algorithm produced consistent and 
valid results. cOnclusiOns: A generalized EM algorithm can be a useful tool to 
estimate TPM, in complex situations where ML estimation and eigen-decomposition 
cannot be used. It allows the use of all the observed data to estimate the TPM, thus 
increasing the accuracy of the health economic models.
PRM69
Patient HeteRogeneity in Cost-effeCtiveness Models foR CHRoniC 
obstRuCtive PulMonaRy disease (CoPd): aRe CuRRent Models suitable 
to evaluate PeRsonalized MediCine
Hoogendoorn M1, Feenstra T2, Asukai Y3, Briggs A4, Borg S5, dal Negro R6, Hansen RN7, 
Jansson S8, Wacker M9, Risebrough N10, Samyshkin Y3, Leidl R9, Rutten van-Mölken M1
1Erasmus University Rotterdam, Rotterdam, The Netherlands, 2RIVM /UMCG, Bilthoven, The 
Netherlands, 3IMS Health, London, UK, 4University of Glasgow, Glasgow, UK, 5Lund University, 
Lund, Sweden, 6National Center for Respiratory Pharmacoeconomics & Pharmacoepidemiology, 
Verona, Italy, 7University of Washington School of Pharmacy, Seattle, WA, USA, 8The OLIN 
Studies, Luleå, Sweden, 9Helmholtz Zentrum Munchen, Neuherberg, Germany, 10ICON plc, 
Toronto, ON, Canada
Objectives: To assess how suitable current COPD cost-effectiveness models are to 
evaluate personalized treatment options for COPD by exploring the type of hetero-
geneity included in current models and by validating outcomes for subgroups of 
patients. MethOds: A consortium of COPD modelling groups participated in three 
evaluations. First, they reported all patient characteristics included in the model and 
provided the level of detail in which the input parameters were specified. Second, 
groups simulated disease progression, mortality, QALYs and costs for hypotheti-
cal subgroups of patients that differed in gender, age, smoking status and FEV1% 
predicted. Finally, model outcomes for exacerbations and mortality for subgroups 
of patients were validated against published subgroup results of two large COPD 
trials. Results: Nine COPD modelling groups participated. Most models included 
gender (7), age (9), smoking status (6) and FEV1% predicted (9), mainly to specify 
disease progression and mortality. Almost all input parameters were specified by 
FEV1% predicted. In addition, disease progression was higher for females and smok-
ers in three and five models, respectively and costs were higher for older patients 
in three models. Differences between subgroups on other parameters were more 
variable between the models. Trial results showed higher exacerbation rates for 
females, which was found in one model, higher mortality rates for males (found 
in two models), lower mortality for younger patients (found in four models), and 
higher exacerbation and mortality rates in severe COPD compared to moderate 
COPD patients (found in four models). cOnclusiOns: The majority of currently 
available COPD cost-effectiveness models are able to evaluate the cost-effectiveness 
of personalized treatment based on gender, age, smoking and FEV1% predicted. 
Treatment in COPD is however, more likely to be personalized based on clinical 
parameters. Two models include several clinical patient characteristics and seem 
most suitable to evaluate personalized treatment, although some important clinical 
parameters are still missing.
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Objectives: To estimate the number of prevalent cases of abdominal aortic aneu-
rysm (AAA) and deaths attributable to AAA in five major European Union (5EU) 
markets: France, Germany, Italy, Spain, and the United Kingdom (UK). MethOds: 
We used disease modeling software, DisMod II (World Health Organization), to 
assess AAA burden via a multi-state life table where differential equations define 
relationships between incidence, prevalence, and disease-specific mortality. 
Market-specific input data included age- and sex-specific population structure, 
age- and sex-specific all-cause mortality, and cubic spline interpolation of size- 
and sex-specific AAA prevalence. Other input data consisted of relative risk (RR) 
estimates of death for persons with AAA compared with persons without AAA, 
adjusted for age, ethnicity, height, weight, smoking, and cardiovascular disease 
history. Results: We estimated 2,484,058 prevalent cases in the 5EU in 2013 (90% 
CI: 2,282,702–2,638,106), resulting in 48,805 deaths attributable to AAA (90% CI: 
39,924–54,291). In the combined 5EU, females accounted for 20.2% of prevalent 
cases and 43.2% of deaths. France had the lowest number of prevalent cases 
(581.8 per 100,000 population) and deaths (11.0 per 100,000 population) among 
the 5EU markets, while Italy had the highest number of prevalent cases (1,103.7 
per 100,000 population) and deaths (22.3 per 100,000 population). The number of 
telemedicine (evaluation of usefulness); • the view of information systems or archi-
tectures. The following characteristics were taken: • purpose of the system; • inter-
action of patients and physicians; • training and impact on lifestyle - the formation 
of health-preserving behaviors (with the exception of smoking, adequate physical 
activity, etc.); • self-management. Results: The following problems of implemen-
tation of telemedicine systems were identified: • high cost, the need to purchase 
special equipment and devices; • the need for training and motivation of both staff 
and patients; • lack of a unified architecture, protocol stack and hardware-software 
platform for the integration of systems at all stages of the process - from data collec-
tion to its processing, decision-making and patient feedback. Despite the fair amount 
of existing telemonitiring systems almost all of its provide only data collection, while 
the entire analytical part falls on the doctor. Almost all of studies were focused on the 
elderly and adults. cOnclusiOns: A promising direction is the development of a 
prototype system for remote health monitoring in pediatric patients. The study was 
supported by the Russian Foundation for Basic Research, the project ¹ 13-04-12055.
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Objectives: Real-world big data accessible through electronic health record (EHR) 
systems offer opportunities to collect generalizable information to populate eco-
nomic models. Using a supervised machine learning approach, the objectives 
were: (a) to mine a hospital EHR for transition probabilities of high-risk patients 
for developing hospital-acquired pressure ulcers (HAPUs); and (b) to compare 
efficiency and accuracy of predictive methods between Markov modeling and 
Bayesian inference with EHR data. MethOds: This study used a de-identified 
panel of patient hospitalizations since 2010 in a U.S. tertiary academic medi-
cal center EHR to study Braden scores of patient risk for developing HAPUs. The 
study focused on patients hospitalized for ≥ 5 days and at least two Braden scores. 
Braden scores were converted from an ordered scale into five categories (i.e. mini-
mal risk; at risk; moderate risk; high risk; very high risk). A 10-stage Markov model 
was constructed via supervised machine learning using R software designating 
the five Braden categories as transition states, as well as end-states for discharge 
or HAPU incidence. Results of the Markov approach were age-adjusted and com-
pared to prior probabilities of HAPU risk derived from naïve and full Bayesian 
inference. Measures of computational accuracy and efficiency were derived to 
compare analytical approaches. Results: The EHR provided a panel of over 34,787 
patients. The Markov model yielded transition probabilities for each of 7 transi-
tions. Patient risk for developing a HAPU is highly predictable after approximately 
4-6 iterations. The very high-risk cohort had a clinically meaningful increase in 
risk for HAPU development of 2.35% compared to a minimal risk transition prob-
ability of 0.05% (p< 0.001). Neither of the Bayesian classifiers provided accurate 
comparisons. cOnclusiOns: Real-world big data from an EHR enables outcomes 
researchers to mine transition probabilities using supervised machine learning. 
These results can be obtained to efficiently populate Markov models for cost-
effectiveness and decision analysis.
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Objectives: Epilepsy lays an important burden on healthcare systems and 
society in general. Disability adjusted life years (DALYs) have been developed to 
compare the burden of this disease both between conditions and between geo-
graphical boundaries. With improving data on disease incidence and prevalence 
in Colombia, we can refine our DALYs-based estimates. MethOds: Using different 
strategies, including the official healthcare provision database (called RIPS) and 
death certificates, as well as extrapolation from published neuroepidemiologic 
studies, we estimated the incidence and prevalence by age groups, the disease 
duration and the attributable mortality. Base don previous studies, we assumed 
an average disability weight of 0.113. With this information, and using the clas-
sic methodology described by Murray & Lopez, we calculated DALYs for the year 
2012. Results: 49,984 (10.4%) of the 479,836 Colombian epilepsy patients are 
in the 15-19 year-old group. Overall, it was found that epilepsy was responsible 
for 0.88% of all deaths (12,837) in Colombia, 8,219 (64%) of them in 60-year olds 
or older. A total of 5.25 DALYs per 1,000 person-years are lost due to epilepsy in 
Colombia, 75% of which (3.91 DALYs) are due to premature mortality, with a higher 
burden in men (6.12 DALYs) than in women (4.41 DALYs). cOnclusiOns: We 
reported new estimations on epilepsy incidence and prevalence by age groups in 
Colombia and conclude that DALYs lost due to epilepsy in Colombia are almost 
double the previous figure, mostly because of the underestimation of attributable 
mortality. With this figure, epilepsy ranks 12th instead of 19th in the list of the 
most important causes of DALYs lost.
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